SCHEMBL878170

SCHEMBL878170

CCCCNc1cccc(-c2nc(Nc3ccc4c(cnn4C(=O)OC(C)(C)C)c3)c3cc(O)ccc3n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.47
ITK Q08881 1/20 0.47
SYK P43405 2/20 0.45
ROCK2 O75116 5/20 0.43
ROCK1 Q13464 3/20 0.43
CHEK2 O96017 2/20 0.43
PAK1 Q13153 2/20 0.43
PRKD2 Q9BZL6 2/20 0.43
PRKACA P17612 1/20 0.43
RPS6KA3 P51812 1/20 0.43
DYRK1A Q13627 1/20 0.43
AURKB Q96GD4 2/20 0.43
PBK Q96KB5 2/20 0.43
SLK Q9H2G2 2/20 0.43
CLK4 Q9HAZ1 2/20 0.43
EEF2K O00418 1/20 0.43
MAP4K4 O95819 1/20 0.43
CLK2 P49760 1/20 0.43
GSK3B P49841 1/20 0.43
PRKX P51817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL877550 0.90 SYK (0.43) SYKROCK2ROCK1CHEK2PAK1
SCHEMBL878169 0.90 PRKD3 (0.51) EGFRITKSYKROCK2ROCK1
SCHEMBL876565 0.89 PRKD3 (0.48) EGFRITKSYKROCK2ROCK1
SCHEMBL877065 0.89 EGFR (0.45) EGFRITKSYKROCK2ROCK1
SCHEMBL4798787 0.86 ROCK2 (0.46) EGFRITKSYKROCK2ROCK1
SCHEMBL877936 0.85 ROCK2 (0.47) EGFRITKSYKROCK2ROCK1
SCHEMBL3792568 0.84 ABCG2 (0.57) EGFRITKSYKROCK2ROCK1
SCHEMBL877451 0.83 ABCG2 (0.55) EGFRITKSYKROCK2ABCG2
SCHEMBL31484237 0.83 ABCG2 (0.55) EGFRITKSYKROCK2ABCG2
SCHEMBL31484236 0.83 ABCG2 (0.55) EGFRITKSYKROCK2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012040499-A2 METABOLIC INHIBITORS SURFACE LOGIX, INC. (US) 2012-03-29 WO disclosed
WO-2008054599-A2 RHO KINASE INHIBITORS SURFACE LOGIX, INC. (US) 2008-05-08 WO disclosed
EP-1865958-A2 PHARMACOKINETICALLY IMPROVED COMPOUNDS Surface Logix, Inc. (US) 2007-12-19 EP disclosed
WO-2006105081-A2 PHARMACOKINETICALLY IMPROVED COMPOUNDS SURFACE LOGIX, INC. (US) 2006-10-05 WO disclosed